Search

everythinglearnresearchcommunity

for

Search:↓

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Women with androgenic alopecia may have a higher risk of artery problems.

There's no significant link between hair loss from male pattern baldness and early heart disease.

There's no clear link between female pattern hair loss and thickness of the carotid artery, but those with hair loss may have thicker arteries. More research is needed.

Men with male pattern baldness had higher body fat and obesity-related measurements but similar heart fat and artery thickness compared to healthy men.

Hair loss may indicate higher heart risk and metabolic issues.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Finasteride may lower cholesterol and slow heart disease progression.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Men with male pattern baldness have increased arterial stiffness.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Hair loss may increase heart disease risk.

Hidden fungal infections might cause heart disease and clogged arteries.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Severe and early hair loss may indicate a higher risk of heart disease.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The report shows a young man with Hutchinson-Gilford Progeria Syndrome had typical and additional eye problems related to the disease.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.